Contribution of subcutaneous fat accumulation to insulin resistance and atherosclerosis in haemodialysis patients

Nephrology Dialysis Transplantation

Volumn 24, Issue 11, 2009, Pages 3474-3480

  Gotoh, Hiromichi ^a,b   Gohda, Tomohito ^a   Tanimoto, Mitsuo ^a   Gotoh, Yoshikazu ^b   Horikoshi, Satoshi ^a   Tomino, Yasuhiko ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Saiyu Souka Hospital   (Japan)

Author keywords

Abdominal fat accumulation; Atherosclerosis; Haemodialysis; Insulin resistance; Intima media thickness

Indexed keywords

ABDOMINAL SUBCUTANEOUS FAT; ADULT; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CARBOHYDRATE METABOLISM; CONTROLLED STUDY; FEMALE; HEMODIALYSIS; HUMAN; INSULIN RESISTANCE; INTRAABDOMINAL FAT; LIPID STORAGE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK FACTOR; AGED; METABOLISM; MIDDLE AGED; REGRESSION ANALYSIS; RENAL REPLACEMENT THERAPY; SUBCUTANEOUS FAT;

ADULT; AGED; ATHEROSCLEROSIS; BODY MASS INDEX; FEMALE; HUMANS; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RENAL DIALYSIS; SUBCUTANEOUS FAT;

EID: 73949113916     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp290     Document Type: Article

References (44)

1. Grobbee DE, Bots ML. Carotid artery intima-media thickness as an indicator of generalized atherosclerosis. J Intern Med 1994; 236: 567-573
2. Bots ML, Hoes AW, Koudataal PJ et al. Common carotid intima-media thickness and risk of stroke and myocardial infarction. The Rotterdam Study. Circulation 1997; 96: 1432-1437
3. Lindner A, Charra B, Sherrard DJ, Scribner BH. Accelerated atherosclerosis patients in prolonged maintenance hemodialysis. N Engl J Med 1974; 290: 697n-701n
4. Kawaguchi T, Nishizawa Y, Konishi T et al. High-resolution B-mode ultrasonography in evaluation of atherosclerosis in uremia. Kidney Int 1995; 48: 820-826
5. Krasniak A, Dorozdz M, Pasowicz M et al. Factors involved in vascular calcification and atherosclerosis in maintenance haemodialysis patients. Nephrol Dial Transplant 2007; 22: 515-521
6. Kovesdy CP, Anderson JE, Kalantar-Zadeh K. Paradoxical association between body mass index and mortality in men with CKD not yet on dialysis. Am J Kidney Dis 2007; 49: 581-591
7. Degoulet P, Legrain M, Réach I et al. Mortality risk factors in patients treated by chronic hemodialysis. Report of the Diaphane collaborative study. Nephron 1982; 31: 103-110
8. Leavey SF, McCullough K, Hecking E et al. Body mass index and mortality in 'healthier' as compared with 'sicker' haemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 2001; 16: 2386-2394
9. Kopple JD, Zhu X, Lew NL, et al. Body weight-for-height relationships predict mortality in maintenance hemodialysis patients. Kidney Int 1999; 56: 1136-1148
10. Fleischmann E, Teal N, Dudley J, et al. Influence of excess weight on mortality and hospital stay in 1346 hemodialysis patients. Kidney Int 1999; 55: 1560-1567
11. Kakiya R, Shoji T, Tsujimoto Y, et al. Body fat mass and lean mass as predictors of survival in hemodialysis patients. Kidney Int 2006; 70: 549-556
12. Ishimura E, Okuno S, Kim M, et al. Increasing body fat mass in the first year of hemodialysis. J Am Soc Nephrol 2001; 12: 1921-1926
13. Qureshi AR, Alvestrand A, Danielsson A, et al. Factors predicting malnutrition in hemodialysis patients: a cross-sectional study. Kidney Int 1998; 53: 773-782
14. Nakamura T, Tokunaga K, Simomura I, et al. Contribution of visceral fat accumulation to the development of coronary artery disease in non-obese men. Atherosclerosis 1994; 107: 239-246
15. DeNino WF, Tchernof A, Dionne IJ, et al. Contribution of abdominal adiposity to age-related differences in insulin sensitivity and plasma lipids in healthy nonobese women. Diabetes Care 2001; 24: 925-932
16. Nagaretani H, Nakamura T, Funahashi T, et al. Visceral Fat is a major contributor for multiple risk factor clustering in Japanese men with impaired glucose tolerance. Diabetes Care 2001; 24: 2127-2133
17. Odamaki M, Furuya R, Ohkawa S, et al. Altered abdominal fat distribution and its association with the serum lipid profile in non-diabetic haemodialysis patients. Nephrol Dial Transplant 1999; 14: 2427-2432
18. Abate N, Garg A, Peshock RM, et al. Relationship of generalized and regional adiposity to insulin sensitivity in men with NIDDM. Diabetes 1996; 45: 1684-1693
19. Goodpaster BH, Thaete FL, Simoneau JA, et al. Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat. Diabetes 1997; 46: 1579-1585
20. Kelley DE, Thaete FL, Troost F, et al. Subdivisions of subcutaneous abdominal adipose tissue and insulin resistance. Am J Physiol En-docrinol Metab 2000; 278: E941-E948
21. Gohda T, Gotoh H, Tanimoto M, et al. Relationship between abdominal fat accumulation and insulin resistance in hemodialysis Patients. Hypertens Res 2008; 31: 83-88
22. Expert committee on the diagnosis and classification of diabetes mel-litus: report on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003; 26(Suppl 1): S5-S20
23. Hayashino Y, Fukuhara S, Akiba T, et al. Diabetes, glycaemic control and mortality risk in patients on haemodialysis: the Japan Dialysis Outcomes and Practice Pattern Study. Diabetologia 2007; 50: 1170-1177
24. Salonen JT, Salonen R. Ultrasonographically assessed carotid morphology and risk of coronary heart disease. Arterioscler Thromb 1991; 11: 1245-1249
25. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and β cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 1985; 28: 412-419
26. Emoto M, Nishizawa Y, Maekawa K, et al. Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas. Diabetes Care 1999; 22: 818-822
27. Shoji T, Emoto M, NIshizawa Y. HOMA index to assess insulin resistance in renal failure patients. Nephron 2001; 89: 348-349
28. Taniguchi A, Nakai Y, Sakai M, et al. Relationship of regional adiposity to insulin resistance and serum triglyceride levels in nonobese Japanese type 2 diabetic patients. Metabolism 2002; 51: 544-548
29. Yamauchi T, Kuno T, Takada H, Nagura Y, Kanmatsuse K, Takahashi S. The impact of visceral fat on multiple risk factors and carotid atherosclerosis in chronic haemodialysis patients. Nephrol Dial Transplant 2003; 18: 1842-1847
30. Axelsson J, Rashid Qureshi A, Suliman ME, et al. Truncal fat mass as a contributor to inflammation in end-stage renal disease. Am J Clin Nutr 2004; 80: 1222-1229
31. Saijo Y, Kiyota N, Kawasaki Y, et al. Relationship between C-reactive protein and visceral adipose issue in healthy Japanese subjects. Diabetes Obes Metab 2004; 6: 249-258
32. De Michele M, Panico S, Iannuzzi A, et al. Association of obesity and central fat distribution with carotid artery wall thickening in middle-aged women. Stroke 2002; 33: 2923-2928
33. Takami R, Takeda N, Hayashi M, et al. Body fatness and fat distribution as predictors of metabolic abnormalities and early carotid atherosclerosis. Diabetes Care 2001; 24: 1248-1252
34. O'Leary DH, Polak JF, Kronmal RA, et al. Cardiovascular Health Study Collaborative Research Group. Thickening of the carotid wall. A marker for atherosclerosis in the elderly? Stroke 1996; 27: 224-231
35. Bots ML, Hofman A, Grobbee DE. Increased common carotid intima-media thickness. Adaptive response or a reflection of atherosclerosis? Findings from the Rotterdam Study. Stroke 1997; 28: 2442-2447
36. Shoji T, Emoto M, Tabata T, et al. Advanced atherosclerosis in pre-dialysis patients with chronic renal failure. Kidney int 2002; 61: 2187-2192
37. Li Y, Bujo H, Takahashi K, et al. Visceral fat: higher responsiveness of fat mass and gene expression to calorie restriction than subcutaneous fat. Exp Biol Med (Maywood) 2003; 228: 1118-1123
38. Wajchenberg BL. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 2000; 21: 697-738
39. Miyazaki Y, Mahankali A, Matsuda M, et al. Effect of pioglita-zone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients. J Clin Endocrinol Metab 2002; 87: 2784-2791
40. Miyazaki Y, Mahankali A, Wajcberg E, et al. Effect of pioglitazone on circulating adipocytokine levels and insulin sensitivity in type 2 diabetic patients. J Clin Endocrinol Metab 2004; 89: 4312-4319
41. Tsuchida A, Yamauchi T, Takekawa S, et al. Peroxisome proliferator-activated receptor (PPAR)alpha activation increases adiponectin receptors and reduces obesity-related inflammation in adipose tissue: comparison of activation of PPARalpha, PPARgamma, and their combination. Diabetes 2005; 54: 3358-3370
42. Yamauchi T, Kamon J, Waki H, et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoat-rophy and obesity. Nature Med 2001; 7: 941-946
43. Zoccali C, Mallamaci F, Tripepi G, et al. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol 2002; 13: 134-141
44. Guebre-Egziabher F, Bernhard J, Funahashi T, et al. Adiponectin in chronic kidney disease is related more to metabolic disturbances than to decline in renal function. Nephrol Dial Transplant 2005; 20: 129-134